Stage III Non-Small Cell Lung Cancer AJCC v7 Completed Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03229278Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or LymphomaTreatment